Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The employee stock ownership plan plans to reduce its shareholding by no more than 3%.
Alis (688578.SH) issued an announcement that the employee stock ownership platforms, Shanghai Aixiang and Nantong Aiyun, plan to conduct bulk transactions...
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) announced that the employee stock platform Shanghai Aixiang and Nantong Aiyun plan to reduce their total holdings of the company's shares by no more than 13.5 million shares through block trading, centralized bidding trading (including fixed-price trading after-hours) starting from September 1, 2025, within a period of 3 months. The planned reduction of shares will not exceed 3% of the total share capital of the company.
Related Articles

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Yiwu Huading Nylon (601113.SH) shareholders in Yiwu Economic Development Zone plan to transfer up to 6% of their shares through public solicitation.
Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Yiwu Huading Nylon (601113.SH) shareholders in Yiwu Economic Development Zone plan to transfer up to 6% of their shares through public solicitation.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


